NSE - Delayed Quote INR

Biocon Limited (BIOCON.NS)

328.15
-1.75
(-0.53%)
At close: 3:30:00 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
150,522,000
150,522,000
141,958,000
109,341,000
80,248,000
Cost of Revenue
51,975,000
51,975,000
48,979,000
36,668,000
27,236,000
Gross Profit
98,547,000
98,547,000
92,979,000
72,673,000
53,012,000
Operating Expense
85,230,000
85,230,000
76,518,000
60,324,000
42,333,000
Operating Income
13,317,000
13,317,000
16,461,000
12,349,000
10,679,000
Net Non Operating Interest Income Expense
-8,974,000
-8,974,000
-9,744,000
-3,066,000
445,000
Pretax Income
18,866,000
18,866,000
15,252,000
8,971,000
9,831,000
Tax Provision
4,572,000
4,572,000
2,274,000
2,541,000
2,115,000
Net Income Common Stockholders
10,133,000
10,133,000
10,225,000
4,627,000
6,484,000
Diluted NI Available to Com Stockholders
10,133,000
10,133,000
10,225,000
4,627,000
6,484,000
Basic EPS
6.72
8.46
8.55
3.88
5.44
Diluted EPS
6.71
8.46
8.54
3.87
5.42
Basic Average Shares
1,196,182.11
1,197,754.14
1,195,906.43
1,193,095.95
1,191,074.68
Diluted Average Shares
1,198,021.95
1,197,754.14
1,197,306.79
1,195,925.59
1,196,351.67
Rent Expense Supplemental
--
--
3,000
29,000
38,000
Total Expenses
137,205,000
137,205,000
125,497,000
96,992,000
69,569,000
Net Income from Continuing & Discontinued Operation
10,133,000
10,133,000
10,225,000
4,627,000
6,484,000
Normalized Income
9,401,858.79
9,401,858.79
10,323,704.96
5,475,300
7,260,880
Interest Income
--
--
1,613,000
1,124,000
1,121,000
Interest Expense
8,974,000
8,974,000
9,744,000
4,190,000
676,000
Net Interest Income
-8,974,000
-8,974,000
-9,744,000
-3,066,000
445,000
EBIT
27,840,000
27,840,000
24,996,000
13,161,000
10,507,000
EBITDA
44,710,000
44,710,000
40,684,000
24,292,000
18,649,000
Reconciled Cost of Revenue
51,975,000
51,975,000
48,979,000
36,668,000
27,236,000
Reconciled Depreciation
16,870,000
16,870,000
15,688,000
11,131,000
8,142,000
Net Income from Continuing Operation Net Minority Interest
10,133,000
10,133,000
10,225,000
4,627,000
6,484,000
Total Unusual Items Excluding Goodwill
965,000
965,000
-116,000
-998,000
-996,000
Total Unusual Items
965,000
965,000
-116,000
-998,000
-996,000
Normalized EBITDA
43,745,000
43,745,000
40,800,000
25,290,000
19,645,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
233,858.79
233,858.79
-17,295.04
-149,700
-219,120
3/31/2022 - 4/7/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ONESOURCE.BO OneSource Specialty Pharma Limited
1,591.75
+0.41%
 
ZOTA.NS Zota Health Care Limited
886.00
+7.69%
 
PANACEABIO.NS Panacea Biotec Limited
513.65
+5.00%
 
SUPRIYA.NS Supriya Lifescience Limited
662.40
+5.31%
 
CONCORDBIO.NS Concord Biotech Limited
1,511.10
-2.11%
 
8279.TWO Syngen Biotech Co.,Ltd.
135.50
+9.72%
 
IDYA IDEAYA Biosciences, Inc.
18.35
+5.34%
 
MGTX MeiraGTx Holdings plc
5.62
+3.69%
 
ZYME Zymeworks Inc.
12.02
+6.32%
 
KOD Kodiak Sciences Inc.
4.1300
+9.55%